15.11
Procedimentos Cegos
Idealmente, as pessoas que observam e registram o comportamento das crianças não sabem quem foi designado para o grupo experimental ou de controle, a…
Os indivíduos podem entrar em estudos com vieses que distorcem os resultados, retratando um tratamento como sendo mais eficaz do que realmente é.
Por exemplo, durante um estudo de insônia, um pesquisador pode colocar um comprimido de sonífero ou placebo em um copo e distribuir as cápsulas para os participantes. Enquanto o cientista observa quem recebeu qual tipo de pílula, os sujeitos estão alheios.
Aqui, o pesquisador permanece tendencioso, antecipando que o sonífero funcionará. Assim, durante a observação, ela pode notar que aqueles que receberam a droga adormeceram mais rápido, enquanto na realidade não há diferença entre os grupos.
No entanto, os vieses dos participantes são eliminados. Como os indivíduos não sabem se engoliram o sonífero, eles não têm expectativas em relação à eficácia da pílula. Consequentemente, eles indicarão com precisão como sua insônia foi afetada.
Esse método, em que apenas pesquisadores ou participantes percebem quem obteve o tratamento, é denominado estudo simples-cego. No entanto, esse procedimento pode resultar em um grupo - aqui, o cientista - permanecendo tendencioso.
Para contornar isso, são realizados estudos duplo-cegos, onde tanto os participantes quanto os pesquisadores da coleta de dados são "cegos". Aqui, o cientista pode dar o placebo e o sonífero a um colega, que renomeia as pílulas como "Tipo Y" e "Tipo Z" antes de dispersá-las.
Esse sistema de codificação elimina as expectativas do pesquisador durante a avaliação - ele não sabe quais participantes receberam a medicação e não pode presumir quem deve dormir melhor. Consequentemente, ela gravará se alguém parecer inquieto.
Como antes, os sujeitos também descreverão com precisão sua experiência de sono. É somente após a análise dos dados que todos ficam sabendo quem recebeu o sonífero ou placebo.
No geral, os procedimentos cegos ajudam a minimizar vieses e produzir resultados precisos, que podem ser usados para avaliar a eficácia de medicamentos e outros tratamentos.
View the full transcript and gain access to JoVE Core videos
Q1: What is experimenter bias and how does it affect research results?
Experimenter bias occurs when a researcher's expectations skew study results. For example, a scientist expecting a sleep-aid to work may note that medicated participants fell asleep faster, even when no actual difference exists. The researcher's anticipation influences how they observe and record data, potentially portraying treatments as more effective than they truly are. Blind procedures help minimize this bias.
Q2: How does a single-blind study control for participant bias?
In a single-blind study, participants remain unaware of whether they received treatment or a placebo, while researchers know group assignments. Since subjects don't know what they received, they lack expectations about efficacy and report their experiences accurately. However, the researcher remains biased during observation and data collection, potentially influencing results through their own expectations.
Q3: What is the placebo effect and why does it matter in research?
The placebo effect occurs when people's expectations or beliefs influence their actual experience. For instance, a participant expecting a pill to improve mood may feel better simply because they took it, not due to any active drug. This expectation-driven response can confound research results, making it difficult to determine whether treatment effects are real or caused by participant expectations alone.
Q4: How does a double-blind study eliminate both researcher and participant bias?
In a double-blind study, neither researchers nor participants know group assignments. A colleague relabels pills as Type Y or Type Z before distribution, preventing the researcher from knowing who received treatment. This coding system eliminates researcher expectations during data collection. Participants also remain blind, preventing placebo effects. Only after analysis does everyone learn actual group assignments.
Q5: Why is blinding important when testing medication effectiveness?
Blinding ensures that observed differences between treatment and control groups reflect actual drug effects rather than bias or expectations. Without blinding, researchers might unconsciously favor treated participants, and participants might experience placebo effects. By keeping both groups blind to assignments, researchers can confidently attribute mood improvements or other outcomes to the medication itself, not to experimenter bias or participant expectations.
Q6: What happens to data collection when researchers know which participants received treatment?
When researchers know treatment assignments, their expectations can bias observations. They may pay more attention to treated participants, interpret ambiguous behaviors favorably for the treatment group, or unconsciously record data differently. This selective attention and interpretation skew results, making treatments appear more effective than they actually are. Blinding the researcher prevents these unconscious influences on data recording.
Q7: How do blind procedures improve the reliability and validity of research findings?
Blind procedures minimize both experimenter and participant biases, producing more accurate results. By preventing researchers from knowing assignments, observations remain objective. By keeping participants unaware, placebo effects are controlled. These protections ensure that measured differences reflect true treatment effects rather than expectations or biases. Consequently, blind procedures strengthen the reliability and validity of conclusions about medication and treatment efficacy.